Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Medrxiv : the Preprint Server for Health Sciences|October 27, 2021
Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer PatientsCong Zeng, John P Evans, Sarah Reisinger, et al.
The Journal of Clinical Investigation|May 24, 2024
Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapyLei Zhou, Maria Velegraki, Yi Wang, et al.
Cell & Bioscience|November 22, 2021
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patientsCong Zeng, John P Evans, Sarah Reisinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technologyMegan K Baker, Kaidi Mikhitarian, Walid Osta, et al.
Cancer Research|July 19, 2005
CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stabilityMelissa M Fraser, Patricia M Watson, Mostafa M Fraig, et al.
Breast Cancer Research and Treatment|June 16, 2021
Prognostic factors for residual occult disease in shave margins during partial mastectomyJulie B Siegel, Rupak Mukherjee, Yeonhee Park, et al.
Breast Cancer Research : BCR|November 7, 2024
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancerJasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
The American Surgeon|May 16, 2015
The impact of surgical diversion before neoadjuvant therapy for rectal cancerBrandon J Anderson, Elizabeth G Hill, Robert E Sweeney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C)Mohamed L Salem, C Marcela Díaz-Montero, Amir A Al-Khami, et al.
The Journal of Molecular Diagnostics : JMD|October 24, 2003
Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]Michael Mitas, Loretta Hoover, Gerard Silvestri, et al.
Pageof 19